Cipla Commits $100 Million Investment To Fund InvaGen Operations & Capex Needs
Published on: March 20, 2026, 8:41 a.m. | Source: Free Press Journal
Cipla Limited has approved an investment of 100 million dollars in its wholly owned subsidiary Cipla (EU) Limited to support the funding requirements of InvaGen Pharmaceuticals Inc. The decision was taken at the board meeting held on March 19, 2026, alongside key leadership and restructuring updates.
